Kiniksa Pharmaceuticals, Ltd.
NASDAQ:KNSA
22.86 (USD) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 112.214 | 108.631 | 79.858 | 83.395 | 67.046 | 71.473 | 48.345 | 61.884 | 99.135 | 26.972 | 32.189 | 18.745 | 12.095 | 7.704 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 49.416 | 42.455 | 31.538 | 26.759 | 26.399 | 21.685 | 7.036 | 14.232 | 11.56 | 5.029 | 4.219 | 3.867 | 2.767 | 2.466 | 0.883 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 62.798 | 66.176 | 48.32 | 56.636 | 40.647 | 49.788 | 41.309 | 47.652 | 87.575 | 21.943 | 27.97 | 14.878 | 9.328 | 5.238 | -0.883 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0.56 | 0.609 | 0.605 | 0.679 | 0.606 | 0.697 | 0.854 | 0.77 | 0.883 | 0.814 | 0.869 | 0.794 | 0.771 | 0.68 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 26.057 | 23.898 | 26.18 | 19.816 | 17.106 | 23.767 | 15.172 | 14.39 | 16.485 | 13.798 | 20.817 | 27.433 | 19.236 | 23.945 | 28.683 | 37.398 | 31.419 | 22.324 | 20.901 | 22.886 | 22.014 | 30.848 | 59.253 | 36.122 | 20.644 | 17.2 | 12.63 | 29.931 | 14.008 | 9.272 | 3.145 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15.5 | 11.799 | 9.536 | 8.486 | 9.695 | 8.432 | 8.441 | 8.394 | 8.013 | 5.515 | 4.327 | 3.71 | 2.78 | 2.241 | 2.12 | 1.903 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.4 | 0 | -0.6 | -0.8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 46.399 | 42.395 | 38.682 | 36.739 | 34.468 | 29.175 | 29.045 | 27.215 | 24.677 | 23.841 | 22.218 | 22.741 | 20.759 | 21.848 | 20.6 | 15.5 | 11.799 | 9.536 | 8.486 | 9.695 | 8.432 | 8.441 | 8.394 | 8.013 | 5.515 | 4.327 | 3.71 | 2.78 | 2.241 | 2.12 | 1.903 |
| Other Expenses
| 20.109 | 2.421 | 2.266 | 2.369 | 2.428 | 1.915 | 8.288 | 0.794 | 6.937 | 3.672 | 8.254 | 0.835 | 2.767 | 2.466 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 72.456 | 66.293 | 64.862 | 56.555 | 51.574 | 52.942 | 52.505 | 41.605 | 41.162 | 41.311 | 51.289 | 51.009 | 39.995 | 45.793 | 49.283 | 52.898 | 43.218 | 31.86 | 29.387 | 32.581 | 30.446 | 39.289 | 67.647 | 44.135 | 26.159 | 21.527 | 16.34 | 32.711 | 16.249 | 11.392 | 5.048 |
| Operating Income
| -9.658 | -0.117 | -16.542 | 0.081 | -10.927 | -3.154 | -11.196 | 6.047 | 46.413 | -19.368 | -23.251 | -36.131 | -30.667 | -40.555 | -49.283 | -52.898 | -43.218 | -31.86 | -29.387 | -32.581 | -30.446 | -39.289 | -67.647 | -44.135 | -26.159 | -21.527 | -16.34 | -32.711 | -16.249 | -11.392 | -5.048 |
| Operating Income Ratio
| -0.086 | -0.001 | -0.207 | 0.001 | -0.163 | -0.044 | -0.232 | 0.098 | 0.468 | -0.718 | -0.722 | -1.928 | -2.536 | -5.264 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 2.457 | 2.421 | 2.266 | 2.369 | 2.428 | 1.915 | 1.832 | 0.794 | 0.322 | 0.103 | -0.034 | 0.077 | 0.005 | 0.006 | 0.009 | 0.03 | 0.049 | 0.266 | 0.789 | 1.13 | 1.386 | 1.724 | 1.809 | 1.727 | 1.622 | 1.066 | 0.305 | 0.133 | 0.169 | 0.153 | 0.074 |
| Income Before Tax
| -7.201 | 2.304 | -14.276 | 2.45 | -8.499 | -1.239 | -9.364 | 6.841 | 46.735 | -19.265 | -23.285 | -36.054 | -30.662 | -40.549 | -49.274 | -52.868 | -43.169 | -31.594 | -28.598 | -31.451 | -29.06 | -37.565 | -65.838 | -42.408 | -24.537 | -20.461 | -16.035 | -32.578 | -16.08 | -11.239 | -4.974 |
| Income Before Tax Ratio
| -0.064 | 0.021 | -0.179 | 0.029 | -0.127 | -0.017 | -0.194 | 0.111 | 0.471 | -0.714 | -0.723 | -1.923 | -2.535 | -5.263 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 5.492 | 6.212 | 3.428 | -22.787 | 5.356 | -16.211 | 2.906 | 2.38 | -177.358 | 0.716 | 1.925 | 0.279 | -0.118 | 1.014 | 0.21 | 0.789 | 0.667 | 5.875 | -2.179 | 0.346 | -2.002 | -0.374 | -0.017 | 0.172 | -0.131 | -0.202 | -0.053 | 0.123 | -0.051 | -0.036 | -0.033 |
| Net Income
| -12.693 | -3.908 | -17.704 | 25.237 | -13.855 | 14.972 | -12.27 | 4.461 | 224.093 | -19.981 | -25.21 | -36.333 | -30.544 | -41.563 | -49.484 | -53.657 | -43.836 | -37.469 | -26.419 | -31.797 | -27.058 | -37.191 | -65.821 | -42.58 | -24.406 | -20.259 | -15.982 | -32.701 | -16.029 | -11.203 | -4.941 |
| Net Income Ratio
| -0.113 | -0.036 | -0.222 | 0.303 | -0.207 | 0.209 | -0.254 | 0.072 | 2.26 | -0.741 | -0.783 | -1.938 | -2.525 | -5.395 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.18 | -0.055 | -0.25 | 0.36 | -0.2 | 0.21 | -0.18 | 0.064 | 3.23 | -0.29 | -0.36 | -0.53 | -0.44 | -0.61 | -0.72 | -0.79 | -0.66 | -0.65 | -0.48 | -0.58 | -0.49 | -0.68 | -1.27 | -0.88 | -0.51 | -1.11 | -0.34 | -1.01 | -0.49 | -0.35 | -0.15 |
| EPS Diluted
| -0.18 | -0.055 | -0.25 | 0.35 | -0.2 | 0.21 | -0.18 | 0.063 | 3.18 | -0.29 | -0.36 | -0.53 | -0.44 | -0.61 | -0.72 | -0.79 | -0.66 | -0.65 | -0.48 | -0.58 | -0.49 | -0.68 | -1.27 | -0.88 | -0.51 | -1.11 | -0.34 | -1.01 | -0.49 | -0.35 | -0.15 |
| EBITDA
| -9.259 | 0.313 | -16.076 | 0.317 | -10.927 | -3.154 | -11.196 | 6.047 | 46.413 | -19.368 | -23.319 | -36.131 | -30.667 | -40.555 | -49.283 | -52.898 | -42.569 | -31.86 | -29.387 | -32.581 | -30.446 | -39.289 | -67.647 | -44.135 | -26.159 | -21.515 | -16.332 | -32.703 | -16.241 | -11.386 | -5.042 |
| EBITDA Ratio
| -0.083 | 0.003 | -0.201 | 0.004 | -0.163 | -0.044 | -0.232 | 0.098 | 0.468 | -0.718 | -0.724 | -1.928 | -2.536 | -5.264 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |